994220903	994220903	CD	B-NP	O
|	|	NN	I-NP	O
TWH	TWH	NN	I-NP	O
|	|	NN	I-NP	O
47066262	47066262	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5052117	5052117	CD	B-NP	O
|	|	CC	I-NP	O
7/29/2006	7/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Volume	Volume	NNP	I-NP	O
Overload	Overload	NNP	I-NP	O
,	,	,	O	O
Upper	Upper	NNP	B-NP	O
GI	GI	NNP	I-NP	O
Bleed	Bleed	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/4/2006	5/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/21/2006	2/21/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HULM	HULM	NN	B-NP	O
,	,	,	O	O
TYRON	TYRON	NN	B-NP	O
916-55-90-2	916-55-90-2	CD	I-NP	O
Alabama	Alabama	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/26/06	7/26/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GODSHALL	GODSHALL	NNP	B-NP	O
,	,	,	O	O
AUBREY	AUBREY	NNP	B-NP	O
HUBERT	HUBERT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
DUONEB	DUONEB	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
AND	AND	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
INH	INH	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BEDTIME	BEDTIME	NN	I-NP	O
ARANESP	ARANESP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DARBEPOETIN	DARBEPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MCG	MCG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
GIVE	GIVE	NNP	B-NP	O
QSATURDAY	QSATURDAY	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FLECAINIDE	FLECAINIDE	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
Sunday	Sunday	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/11	1/11	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
PLEASE	PLEASE	NN	B-NP	O
CHECK	CHECK	NN	I-NP	O
CREATININE	CREATININE	NN	I-NP	O
TO	TO	TO	B-PP	O
MONITOR	MONITOR	NN	B-NP	O
RENAL	RENAL	NN	I-NP	O
FUNCTION	FUNCTION	NN	I-NP	O
ON	ON	NN	I-NP	O
INCREASED	INCREASED	VBD	B-VP	O
DOSE	DOSE	NN	B-NP	O
OF	OF	IN	B-PP	O
LASIX	LASIX	NN	B-NP	B-protein
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/4/06	5/4/06	CD	B-NP	O
by	by	IN	B-PP	O
POLEK	POLEK	NNP	B-NP	B-protein
,	,	,	O	O
WILFORD	WILFORD	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
150382328	150382328	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
CHLOROTHIAZIDE	CHLOROTHIAZIDE	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Rash	Rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
12.5	12.5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/6/06	7/6/06	CD	B-NP	O
by	by	IN	B-PP	O
DESREVISSEAU	DESREVISSEAU	NNP	B-NP	O
,	,	,	O	O
PASQUALE	PASQUALE	NNP	B-NP	O
L	L	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
884931474	884931474	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
CHLOROTHIAZIDE	CHLOROTHIAZIDE	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Rash	Rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
VICODIN	VICODIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCODONE	HYDROCODONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-VP	O
APAP	APAP	NN	B-NP	O
500MG	500MG	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Pain	Pain	NN	I-NP	O
HYDROXYZINE	HYDROXYZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/11	1/11	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Itching	Itching	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	B-protein
NPH	NPH	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
75	75	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/4/06	5/4/06	CD	B-NP	O
by	by	IN	B-PP	O
BUCKHANAN	BUCKHANAN	NNP	B-NP	O
,	,	,	O	O
ELDON	ELDON	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
316221946	316221946	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
SAKSHAUG	SAKSHAUG	NN	B-NP	O
,	,	,	O	O
DANE	DANE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
866425198	866425198	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NADOLOL	NADOLOL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PRILOSEC	PRILOSEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	B-RNA
Starting	Starting	NNP	I-NP	I-RNA
Today	Today	NNP	I-NP	I-RNA
-LRB-	-LRB-	NNP	I-NP	I-RNA
1/11	1/11	CD	I-NP	I-RNA
-RRB-	-RRB-	NNP	I-NP	I-RNA
PRILOSEC	PRILOSEC	NNP	I-NP	I-RNA
-LRB-	-LRB-	NNP	I-NP	I-RNA
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	I-RNA
-RRB-	-RRB-	NNP	I-NP	I-RNA
20	20	CD	I-NP	I-RNA
MG	MG	NNP	I-NP	I-RNA
PO	PO	NNP	I-NP	I-RNA
QPM	QPM	NNP	I-NP	I-RNA
SARNA	SARNA	NNP	I-NP	I-RNA
TOPICAL	TOPICAL	NNP	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/4/06	5/4/06	CD	B-NP	O
by	by	IN	B-PP	O
SWINGER	SWINGER	NN	B-NP	O
,	,	,	O	O
TEDDY	TEDDY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
316221946	316221946	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
RANDKLEV	RANDKLEV	NN	B-NP	O
,	,	,	O	O
MORGAN	MORGAN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
866425198	866425198	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
SALINE	SALINE	NNP	B-NP	O
NASAL	NASAL	NNP	I-NP	O
DROP	DROP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
0.65	0.65	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
nasal	nasal	JJ	B-NP	O
dryness	dryness	NN	I-NP	O
,	,	,	O	O
congestion	congestion	NN	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/4/06	5/4/06	CD	B-NP	O
by	by	IN	B-PP	O
STOTZ	STOTZ	NN	B-NP	B-protein
,	,	,	O	O
GREGG	GREGG	NNP	B-NP	O
Z.	Z.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Sung	Sung	NNP	I-NP	O
Satterlund	Satterlund	NNP	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
followup	followup	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Almerico	Almerico	NNP	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
151-030-7040	151-030-7040	CD	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Mitchel	Mitchel	NNP	I-NP	O
Tolayo	Tolayo	NNP	I-NP	O
,	,	,	O	O
Tagedether	Tagedether	NNP	B-NP	O
Kony	Kony	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
2/5/06	2/5/06	CD	I-NP	O
at	at	IN	B-PP	O
09	09	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/26/06	7/26/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
RODENBOUGH	RODENBOUGH	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	O
,	,	,	O	O
CHLOROTHIAZIDE	CHLOROTHIAZIDE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Volume	Volume	NN	B-NP	O
Overload	Overload	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Volume	Volume	NNP	I-NP	O
Overload	Overload	NNP	I-NP	O
,	,	,	O	O
Upper	Upper	NNP	B-NP	O
GI	GI	NNP	I-NP	O
Bleed	Bleed	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
PVD	PVD	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
bilat	bilat	NN	I-NP	O
iliac	iliac	JJ	I-NP	O
stents	stent	NNS	I-NP	O
-LRB-	-LRB-	HYPH	O	O
10/4	10/4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
AVR/MVR	AVR/MVR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
AFib	AFib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
RHD	RHD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
rheumatic	rheumatic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OA	OA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Diverticulosis	Diverticulosis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gout	Gout	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
gout	gout	VBD	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NONE	NONE	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Attg	Attg	NNP	B-NP	O
-	-	:	O	O
Frank	Frank	NNP	B-NP	O
Ratzloff	Ratzloff	NNP	I-NP	O
outpt	outpt	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-	-	HYPH	B-NP	O
Sibayan	Sibayan	NN	I-NP	O
--	--	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
hct	hct	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
77F	77F	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
diverticular	diverticular	JJ	I-NP	I-protein
GIB	GIB	NN	I-NP	I-protein
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	B-protein
who	who	WP	B-NP	I-protein
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hct	hct	JJ	I-NP	O
drop	drop	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
30	30	CD	I-NP	O
to	to	TO	B-PP	O
26	26	CD	B-NP	O
and	and	CC	I-NP	O
strongly	strongly	RB	I-NP	O
guiac	guiac	JJ	I-NP	O
+	+	SYM	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
bioprosthetic	bioprosthetic	JJ	B-NP	O
MVR	MVR	NN	I-NP	O
and	and	CC	I-NP	O
AVR	AVR	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
black	black	JJ	B-NP	O
,	,	,	I-NP	O
tarry	tarry	JJ	I-NP	O
stools	stool	NNS	I-NP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
diverticular	diverticular	JJ	I-NP	O
GIB	GIB	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
GRH	GRH	NN	B-NP	B-protein
ED	ED	VBD	B-VP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
PTA	PTA	NN	I-NP	O
for	for	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
and	and	CC	O	O
discharged	discharge	VBN	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
trouble	trouble	NN	B-NP	O
starting	start	VBG	B-VP	O
urination	urination	NN	B-NP	O
,	,	,	O	O
joint	joint	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
HA	HA	NN	B-NP	O
,	,	,	O	O
itching	itch	VBG	B-VP	O
since	since	IN	B-PP	O
abx	abx	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
regurgitation	regurgitation	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
pericardial	pericardial	JJ	I-NP	I-protein
MVR	MVR	NN	I-NP	I-protein
and	and	CC	I-NP	O
AVR	AVR	NN	I-NP	B-protein
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
aspiration	aspiration	NN	I-NP	O
pna	pna	NN	I-NP	O
in	in	IN	B-PP	O
6/19	6/19	CD	B-NP	O
PSH	PSH	NN	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
fem-pop	fem-pop	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
8/27	8/27	CD	B-NP	O
c/b	c/b	NN	I-NP	O
allergic	allergic	JJ	I-NP	O
abx	abx	NN	I-NP	O
rxn	rxn	NN	I-NP	O
and	and	CC	O	O
damage	damage	NN	B-NP	O
to	to	TO	B-PP	O
vocal	vocal	JJ	B-NP	O
cords	cord	NNS	I-NP	O
.	.	.	O	O

Meds	Med	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
:	:	:	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d	b.i.d	FW	I-NP	O
Flecainide	Flecainide	NN	I-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
12h	12h	CD	I-NP	O
Lasix	Lasix	NNP	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
bid	bid	NN	I-NP	O
Hydrochlorothiazide	Hydrochlorothiazide	NN	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
Vicodin	Vicodin	NNP	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
hydroxyzine	hydroxyzine	NN	I-NP	O
10-20	10-20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
itching	itch	VBG	B-VP	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subq	subq	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
levothyroxine	levothyroxine	NN	I-NP	I-protein
75	75	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
nadolol	nadolol	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
Sarna	Sarna	NNP	I-NP	I-protein
topical	topical	JJ	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
Zocor	Zocor	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
Ocean	Ocean	NNP	I-NP	O
Nasal	Nasal	NNP	I-NP	O
Spray	Spray	NNP	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	JJ	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
p.m.	p.m.	NN	I-NP	O
All	All	DT	B-NP	O
:	:	:	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
lip	lip	NN	B-NP	O
swelling	swelling	NN	I-NP	O
?	?	.	O	O

skin	skin	NN	B-NP	O
sloughing	sloughing	NN	I-NP	O
;	;	:	O	O
chlorothiazide	chlorothiazide	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

SH	SH	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
tobacc	tobacc	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
rehab	rehab	NN	B-NP	O
since	since	IN	B-PP	O
surgery	surgery	NN	B-NP	O
FH	FH	NN	I-NP	O
:	:	:	O	O
nc	nc	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Daily	Daily	JJ	I-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
improved	improve	VBD	B-VP	O
,	,	,	O	O
afebrile	afebrile	RB	B-ADVP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
@	@	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
120	120	CD	B-NP	O
lasix	lasix	CD	I-NP	O
iv	iv	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
this	this	DT	B-NP	O
am	am	NN	I-NP	O
;	;	:	O	O
I/O	I/O	NN	B-NP	O
goal	goal	NN	I-NP	O
-500	-500	CD	B-NP	O
to	to	TO	I-NP	O
-1	-1	CD	I-NP	O
L	L	NN	I-NP	O
;	;	:	O	O
Off	Off	IN	B-PP	O
plavix	plavix	NN	B-NP	O
;	;	:	O	O
INR	INR	NN	B-NP	O
1.8	1.8	CD	I-NP	O
today	today	NN	B-NP	O
-LRB-	-LRB-	SYM	B-VP	O
usu	usu	NN	B-NP	O
1.7	1.7	CD	I-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Reasons	Reasons	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Admission	Admission	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	O
P64	P64	NN	I-NP	O
BP144/58	BP144/58	NN	I-NP	O
RR	RR	NN	I-NP	O
18	18	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
,	,	,	O	O
Aox3	Aox3	NN	B-NP	B-protein
;	;	:	O	O
bilateral	bilateral	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
to	to	TO	B-VP	O
halfway	halfway	VB	I-VP	O
up	up	RP	B-PRT	O
;	;	:	O	O
CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
RRR	RRR	NN	I-NP	B-protein
,	,	,	O	O
III/VI	III/VI	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
axilla	axilla	NN	B-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
best	best	RB	B-ADVP	O
heard	hear	VBD	B-VP	O
at	at	IN	B-PP	O
LLSB	LLSB	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
>	>	SYM	O	O
15	15	CD	B-NP	O
;	;	:	O	O
Abd	Abd	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
hypoactive	hypoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
well-healed	well-healed	JJ	I-NP	O
incisions	incision	NNS	I-NP	O
,	,	,	O	O
distended	distended	JJ	B-NP	O
and	and	CC	I-NP	O
firm	firm	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
in	in	IN	B-PP	O
flanks	flank	NNS	B-NP	O
bilaterally	bilaterally	RB	B-NP	O
Extr	Extr	NN	I-NP	O
-	-	HYPH	B-NP	O
warm	warm	JJ	I-NP	O
,	,	,	I-NP	O
chronic	chronic	JJ	I-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
thighs	thigh	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	O
60	60	CD	I-NP	O
bpm	bpm	NN	I-NP	O
,	,	,	O	O
1st	1st	JJ	B-NP	O
degree	degree	NN	I-NP	O
AVB	AVB	NN	I-NP	O
.	.	.	O	O

Incomplete	Incomplete	JJ	B-NP	O
RBBB	RBBB	NN	I-NP	B-protein
.	.	.	O	O

S	S	NN	B-NP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
q	q	NN	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
A/P	A/P	NN	B-NP	O
:	:	:	O	O
77F	77F	NN	B-NP	O
with	with	IN	B-PP	O
MMP	MMP	NN	B-NP	B-protein
including	include	VBG	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
MS	MS	NN	B-NP	O
,	,	,	O	O
AS	AS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
AVR/MVR	AVR/MVR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
prior	prior	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
GIB	GIB	NN	B-NP	B-protein
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
hematocrit	hematocrit	NN	I-NP	B-protein
2/2	2/2	CD	I-NP	I-protein
presumed	presume	VBN	I-NP	I-protein
slow	slow	JJ	I-NP	I-protein
GIB	GIB	NN	I-NP	I-protein
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
GIB	GIB	NN	I-NP	B-protein
in	in	IN	B-PP	O
past	past	NN	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
diverticular	diverticular	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

2	2	CD	B-NP	O
large	large	JJ	I-NP	O
bore	bore	JJ	I-NP	O
IVs	IV	NNS	I-NP	O
.	.	.	O	O

Type	Type	NN	B-NP	O
and	and	CC	O	O
crossmatch	crossmatch	VB	B-VP	O
PRBC	PRBC	NNP	B-NP	B-cell_type
.	.	.	O	O

Transfuse	Transfuse	NN	B-NP	O
for	for	IN	B-PP	O
HCT	HCT	NN	B-NP	B-DNA
<	<	SYM	B-NP	I-DNA
25	25	CD	I-NP	I-DNA
.	.	.	O	O

Check	Check	NNP	B-NP	O
q12hour	q12hour	NN	I-NP	O
hcts	hct	NNS	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
PPI	PPI	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Guiac	Guiac	JJ	B-NP	O
all	all	DT	I-NP	O
stools	stool	NNS	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
guaiac	guaiac	JJ	B-ADJP	O
positive	positive	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
but	but	CC	I-NP	O
WITHOUT	WITHOUT	NN	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	O
stable	stable	JJ	I-NP	O
x	x	NN	I-NP	O
>	>	SYM	B-VP	O
24h	24h	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
e/o	e/o	RB	I-NP	O
acute	acute	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
conservative	conservative	JJ	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
bioprosthetic	bioprosthetic	JJ	B-NP	O
MVR	MVR	NN	I-NP	O
and	and	CC	I-NP	O
AVR	AVR	NN	I-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
at	at	IN	B-PP	O
present	present	NN	B-NP	O
,	,	,	O	O
1.7-1	1.7-1	CD	B-NP	O
.9	.9	CD	I-NP	O
.	.	.	O	O

Held	Held	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
initailly	initailly	RB	B-ADVP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
10/27	10/27	CD	B-NP	O
once	once	RB	B-ADVP	O
at	at	IN	B-PP	O
1.8	1.8	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
hold	hold	VB	I-VP	O
plavix	plavix	NN	B-NP	O
indefinitely	indefinitely	RB	B-VP	O
given	give	VBN	I-VP	O
bleeding	bleed	VBG	B-VP	O
risk	risk	NN	B-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
hct	hct	NN	I-NP	O
@	@	NN	I-NP	O
27	27	CD	I-NP	O
throughout	throughout	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
HCT	HCT	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
however	however	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
acute	acute	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
value	value	NN	I-NP	O
back	back	RB	B-ADVP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Checked	Check	VBN	B-NP	O
SPEP	SPEP	NN	I-NP	O
and	and	CC	I-NP	O
UPEP	UPEP	NN	I-NP	O
given	give	VBN	B-PP	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	O
;	;	:	O	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
as	as	IN	B-PP	O
out-patient	out-patient	JJ	B-ADJP	O
for	for	IN	B-PP	O
Multiple	Multiple	JJ	B-NP	O
Myeloma	Myeloma	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
ischemia	ischemia	NN	I-NP	O
:	:	:	O	O
clean	clean	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
plavix	plavix	NN	B-NP	O
for	for	IN	B-PP	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
will	will	MD	B-VP	O
hold	hold	VB	I-VP	O
indefinitely	indefinitely	RB	I-VP	O
given	give	VBN	I-VP	O
recurrent	recurrent	JJ	B-NP	O
GIB	GIB	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
pump	pump	NN	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
nadolol	nadolol	NN	B-NP	O
.	.	.	O	O

Baseline	Baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
1.9-2	1.9-2	CD	I-NP	O
.3	.3	NN	I-NP	O
.	.	.	O	O

Appears	Appear	VBZ	B-VP	O
vol	vol	NN	B-NP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
diuresised	diuresised	JJ	B-NP	O
approx	approx	NN	I-NP	O
1	1	CD	I-NP	O
L	L	NN	I-NP	O
over	over	IN	B-PP	O
48h	48h	NN	B-NP	O
.	.	.	O	O

Transitioned	Transitione	VBN	B-VP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	B-protein
lasix	lasix	CD	I-NP	I-protein
regimen	regimen	NN	I-NP	I-protein
7/10	7/10	CD	B-NP	I-protein
,	,	,	O	O
at	at	IN	B-PP	O
increased	increase	VBN	B-NP	O
dose	dose	NN	I-NP	O
160	160	CD	I-NP	O
PO	PO	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
echo	echo	NN	I-NP	O
6/19	6/19	CD	I-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Brunke	Brunke	NNP	I-NP	O
Repeat	Repeat	NNP	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
rhythm	rhythm	NN	I-NP	O
:	:	:	O	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
afib	afib	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
flecainide	flecainide	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
synthroid	synthroid	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
high	high	JJ	B-ADJP	O
at	at	IN	B-PP	O
5.5	5.5	CD	B-NP	O
,	,	,	O	O
FT4	FT4	NN	B-NP	B-protein
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Code	Code	NNP	B-NP	O
:	:	:	O	O
DNR/DNI	DNR/DNI	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
between	between	IN	B-PP	O
1.7	1.7	CD	B-NP	O
and	and	CC	I-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
fax	fax	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Patak	Patak	NNP	I-NP	O
'	'	POS	B-NP	O
office	office	NN	I-NP	O
at	at	IN	B-PP	O
576-178-3020	576-178-3020	CD	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
Creatinine	Creatinine	NN	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	DT	O	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
Lasix	Lasix	NN	I-NP	B-protein
regimen	regimen	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
to	to	TO	I-VP	O
160mg	160mg	VB	I-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
from	from	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
daily	daily	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
-RRB-	-RRB-	:	O	B-protein
You	You	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
Upper	Upper	NNP	I-NP	O
GI	GI	NNP	I-NP	O
bleed	bleed	VBD	B-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
plavix	plavix	NN	B-NP	O
.	.	.	O	O

STOP	STOP	NN	B-NP	B-protein
taking	take	VBG	B-VP	O
Plavix	Plavix	NNP	B-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
HCT	HCT	NN	I-NP	O
falls	fall	VBZ	B-VP	O
between	between	IN	B-NP	O
27	27	CD	I-NP	O
and	and	CC	I-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
SPEP/UPEP	SPEP/UPEP	NN	I-NP	O
and	and	CC	I-NP	O
Free	Free	JJ	I-NP	O
T4	T4	NN	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Have	Have	NNP	I-NP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
re-evaluate	re-evaluate	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
next	next	JJ	I-NP	O
visit	visit	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Your	Your	PRP$	B-NP	O
Prilosec	Prilosec	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
QAM	QAM	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
QPM	QPM	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
between	between	IN	B-PP	O
1.7	1.7	CD	B-NP	O
and	and	CC	I-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
fax	fax	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Antwan	Antwan	NNP	I-NP	O
H	H	NNP	I-NP	O
Heman	Heman	NNP	I-NP	O
at	at	IN	B-PP	O
576-178-3020	576-178-3020	CD	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
Creatinine	Creatinine	NN	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	DT	O	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
Lasix	Lasix	NN	I-NP	B-protein
regimen	regimen	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
to	to	TO	I-VP	O
160mg	160mg	VB	I-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
from	from	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
daily	daily	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
-RRB-	-RRB-	:	O	B-protein
You	You	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
Upper	Upper	NNP	I-NP	O
GI	GI	NNP	I-NP	O
bleed	bleed	VBD	B-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
plavix	plavix	NN	B-NP	O
.	.	.	O	O

STOP	STOP	NN	B-NP	B-protein
taking	take	VBG	B-VP	O
Plavix	Plavix	NNP	B-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
HCT	HCT	NN	I-NP	O
falls	fall	VBZ	B-VP	O
between	between	IN	B-NP	O
27	27	CD	I-NP	O
and	and	CC	I-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
SPEP/UPEP	SPEP/UPEP	NN	I-NP	O
,	,	,	I-NP	O
Erythropoeitin	Erythropoeitin	NN	I-NP	B-protein
and	and	CC	I-NP	O
Free	Free	JJ	I-NP	O
T4	T4	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Have	Have	NNP	I-NP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
re-evaluate	re-evaluate	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
next	next	JJ	I-NP	O
visit	visit	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Your	Your	PRP$	B-NP	O
Prilosec	Prilosec	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
QAM	QAM	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
QPM	QPM	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
STOPP	STOPP	NN	B-NP	B-protein
,	,	,	O	O
CESAR	CESAR	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NU14	NU14	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/26/06	7/26/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

